BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 12590162)

  • 1. Aggresome formation by mutant prion proteins: the unfolding role of proteasomes in familial prion disorders.
    Mishra RS; Bose S; Gu Y; Li R; Singh N
    J Alzheimers Dis; 2003 Feb; 5(1):15-23. PubMed ID: 12590162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular phenotyping of secretory and nuclear prion proteins associated with inherited prion diseases.
    Lorenz H; Windl O; Kretzschmar HA
    J Biol Chem; 2002 Mar; 277(10):8508-16. PubMed ID: 11756421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant prion protein D202N associated with familial prion disease is retained in the endoplasmic reticulum and forms 'curly' intracellular aggregates.
    Gu Y; Verghese S; Bose S; Mohan M; Singh N
    J Mol Neurosci; 2007; 32(1):90-6. PubMed ID: 17873292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the histo-molecular pathology of human prion disease.
    Baiardi S; Rossi M; Capellari S; Parchi P
    Brain Pathol; 2019 Mar; 29(2):278-300. PubMed ID: 30588685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial mutations and the thermodynamic stability of the recombinant human prion protein.
    Swietnicki W; Petersen RB; Gambetti P; Surewicz WK
    J Biol Chem; 1998 Nov; 273(47):31048-52. PubMed ID: 9813003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic mice recapitulate the phenotypic heterogeneity of genetic prion diseases without developing prion infectivity: Role of intracellular PrP retention in neurotoxicity.
    Chiesa R; Restelli E; Comerio L; Del Gallo F; Imeri L
    Prion; 2016 Mar; 10(2):93-102. PubMed ID: 26864450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and infectious prion diseases.
    Prusiner SB
    Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A trend of molecular genetics on prion diseases and prion protein].
    Muramatsu Y; Shinagawa M
    Nihon Rinsho; 1993 Sep; 51(9):2494-502. PubMed ID: 8411733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer's Disease and Other Neurodegenerative Disorders.
    Carlson GA; Prusiner SB
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34064393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular approaches to mechanisms of prion diseases.
    Bratosiewicz-Wasik J; Wasik TJ; Liberski PP
    Folia Neuropathol; 2004; 42 Suppl A():33-46. PubMed ID: 15449458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prion diseases.
    Brown K; Mastrianni JA
    J Geriatr Psychiatry Neurol; 2010 Dec; 23(4):277-98. PubMed ID: 20938044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysosomal Quality Control in Prion Diseases.
    Majumder P; Chakrabarti O
    Mol Neurobiol; 2018 Mar; 55(3):2631-2644. PubMed ID: 28421536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins.
    Asante EA; Gowland I; Grimshaw A; Linehan JM; Smidak M; Houghton R; Osiguwa O; Tomlinson A; Joiner S; Brandner S; Wadsworth JDF; Collinge J
    J Gen Virol; 2009 Mar; 90(Pt 3):546-558. PubMed ID: 19218199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation.
    Ma J; Lindquist S
    Proc Natl Acad Sci U S A; 2001 Dec; 98(26):14955-60. PubMed ID: 11742063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Anchorless Human PrP With Q227X Stop Mutation Linked to Gerstmann-Sträussler-Scheinker Syndrome In Vivo and In Vitro.
    Shen P; Dang J; Wang Z; Zhang W; Yuan J; Lang Y; Ding M; Mitchell M; Kong Q; Feng J; Rozemuller AJM; Cui L; Petersen RB; Zou WQ
    Mol Neurobiol; 2021 Jan; 58(1):21-33. PubMed ID: 32889654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteasomal degradation and N-terminal protease resistance of the codon 145 mutant prion protein.
    Zanusso G; Petersen RB; Jin T; Jing Y; Kanoush R; Ferrari S; Gambetti P; Singh N
    J Biol Chem; 1999 Aug; 274(33):23396-404. PubMed ID: 10438517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic background of human prion diseases].
    Kovács GG
    Ideggyogy Sz; 2007 Nov; 60(11-12):438-46. PubMed ID: 18198790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prion diseases: Creutzfeldt-Jakob, Gerstmann-Sträussler-Scheinker, and related disorders.
    Mastrianni JA
    J Geriatr Psychiatry Neurol; 1998; 11(2):78-97. PubMed ID: 9877529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel missense variants of prion protein in Creutzfeldt-Jakob disease or Gerstmann-Sträussler syndrome.
    Kitamoto T; Ohta M; Doh-ura K; Hitoshi S; Terao Y; Tateishi J
    Biochem Biophys Res Commun; 1993 Mar; 191(2):709-14. PubMed ID: 8461023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.